Elevance Health (ELV) income statement
NYSE · Healthcare · Medical - Healthcare Plans · 96,615 employees · CEO Gail Koziara Boudreaux
- Price
- $420.07 -0.46%
- Market cap
- $91.1B
- Enterprise value
- $112B
- Last report
- Q3 '26 filed 2026-10-21
- Next report
- 2027-01-27 EPS est. $2.08
Elevance Health (ELV) reported revenue of $51.4B for Q3 '26 (+1.4% year on year), operating income of $2.15B (4.2% of revenue) and net income of $1.37B. Over the last four quarters revenue was $202B.
Income statement
| Income statement | Trend | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42.6B | $42.6B | $43.6B | $45.1B | $45.4B | $48.9B | $49.8B | $50.7B | $49.7B | $50.2B | $50.5B | $51.4B | |
| Cost of revenue | $31.3B | $30.5B | $30.6B | $32.9B | $33.5B | $35.3B | $36.7B | $38.1B | $38.1B | $41.1B | $5.49B | $43.4B | |
| Gross profit | $11.3B | $12B | $13.1B | $12.2B | $11.9B | $13.6B | $13.1B | $12.6B | $11.7B | $9.1B | $45B | $8.01B | |
| General & administrative | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6.33B | $0 | $0 | |
| Other operating expenses | $10.1B | $8.83B | $10B | $10.5B | $11B | $10.4B | $10.4B | $10.8B | $11.1B | $112M | $42.9B | $106M | |
| Operating expenses | $10.1B | $8.83B | $10B | $10.5B | $11B | $10.4B | $10.4B | $10.8B | $11.1B | $6.44B | $42.9B | $5.86B | |
| Operating income | $1.26B | $3.2B | $3.03B | $1.71B | $946M | $3.14B | $2.63B | $1.76B | $581M | $2.66B | $2.06B | $2.15B | |
| Interest income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $704M | $0 | |
| Interest expense | $259M | $265M | $280M | $300M | $340M | $344M | $341M | $351M | $366M | $357M | $56M | $358M | |
| Other non-operating income (gains on investments, FX ...) | $0 | $0 | -$240M | $39M | $0 | $0 | $0 | $0 | $0 | $0 | $70M | $0 | |
| Total non-operating income | -$259M | -$265M | -$40M | -$339M | -$340M | -$344M | -$341M | -$351M | -$366M | -$357M | -$126M | -$358M | |
| Income before tax | $1B | $2.94B | $2.99B | $1.37B | $606M | $2.8B | $2.29B | $1.41B | $215M | $2.3B | $1.94B | $1.79B | |
| Income tax | $170M | $690M | $685M | $365M | $193M | $613M | $548M | $219M | -$331M | $544M | $483M | $451M | |
| Net income | $856M | $2.25B | $2.3B | $1.02B | $418M | $2.18B | $1.74B | $1.19B | $547M | $1.76B | $1.46B | $1.37B | |
| EPS (basic) | $3.67 | $9.65 | $9.91 | $4.36 | $1.84 | $9.64 | $7.72 | $5.32 | $2.47 | $8.00 | $6.71 | $6.30 | |
| EPS (diluted) | $3.63 | $9.59 | $9.85 | $4.36 | $1.81 | $9.61 | $7.72 | $5.32 | $2.47 | $8.00 | $6.71 | $6.27 | |
| Shares (basic, weighted) | 233M | 233M | 232M | 233M | 227M | 226M | 226M | 226M | 222M | 220M | 218M | 218M | |
| Shares (diluted, weighted) | 236M | 234M | 233M | 233M | 231M | 227M | 226M | 226M | 222M | 220M | 218M | 218M | |
| Depreciation & amortization | $424M | $331M | $335M | $329M | $398M | $373M | $380M | $387M | $406M | $354M | $366M | $363M | |
| EBITDA | $1.68B | $3.54B | $3.6B | $2B | $1.34B | $3.51B | $3.01B | $2.14B | $987M | $3.02B | $2.36B | $2.52B |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $85B | $90B | $92.1B | $104B | $122B | $139B | $157B | $171B | $177B | $199B | |
| Cost of revenue | $66.8B | $72.2B | $71.9B | $81.8B | $88B | $103B | $117B | $124B | $128B | $148B | |
| Gross profit | $18.1B | $17.8B | $20.2B | $22.4B | $33.8B | $36B | $40B | $47B | $49.2B | $50.9B | |
| Other operating expenses | $12.7B | $12.8B | $14.4B | $15.7B | $26.1B | $27B | $31.5B | $38.3B | $40.4B | $42.8B | |
| Operating expenses | $12.7B | $12.8B | $14.4B | $15.7B | $26.1B | $27B | $31.5B | $38.3B | $40.4B | $42.8B | |
| Operating income | $5.42B | $4.99B | $5.84B | $6.73B | $7.71B | $8.95B | $8.45B | $8.75B | $8.89B | $8.11B | |
| Interest expense | $723M | $739M | $753M | $746M | $784M | $798M | $851M | $1.03B | $1.19B | $1.4B | |
| Other non-operating income (gains on investments, FX ...) | $141M | $282M | $16M | $2M | $689M | $223M | $0 | $0 | -$201M | $0 | |
| Total non-operating income | -$864M | -$1.02B | -$769M | -$748M | -$1.47B | -$1.02B | -$851M | -$1.03B | -$984M | -$1.4B | |
| Income before tax | $4.56B | $3.96B | $5.07B | $5.99B | $6.24B | $7.93B | $7.6B | $7.72B | $7.9B | $6.71B | |
| Income tax | $2.09B | $121M | $1.32B | $1.18B | $1.67B | $1.83B | $1.71B | $1.72B | $1.93B | $1.05B | |
| Net income | $2.47B | $3.84B | $3.75B | $4.81B | $4.57B | $6.1B | $5.89B | $5.99B | $5.98B | $5.66B | |
| EPS (basic) | $9.39 | $14.70 | $14.53 | $18.81 | $18.23 | $25.25 | $24.56 | $25.38 | $25.81 | $25.18 | |
| EPS (diluted) | $9.21 | $14.35 | $14.19 | $18.47 | $17.98 | $24.73 | $24.28 | $25.22 | $25.68 | $25.12 | |
| Shares (basic, weighted) | 264M | 256M | 254M | 256M | 251M | 244M | 240M | 233M | 233M | 222M | |
| Shares (diluted, weighted) | 268M | 268M | 254M | 260M | 254M | 247M | 243M | 237M | 233M | 222M | |
| Depreciation & amortization | $912M | $891M | $1.13B | $1.13B | $1.15B | $1.3B | $1.68B | $1.75B | $1.39B | $1.55B | |
| EBITDA | $6.19B | $5.59B | $6.95B | $7.86B | $8.18B | $10B | $10.1B | $10.5B | $10.5B | $9.66B |
Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-01